Studies of pancreatic alpha cell function in normal and diabetic subjects.

The development of a glucagon radioimmunoassay with a relatively high degree of specificity for pancreatic glucagon made possible studies of alpha cell function in healthy nondiabetic subjects and in patients with diabetes mellitus. In the former group mean fasting plasma glucagon averaged 108 mumug/ml (SEM +/-10). In 12 juvenile-type diabetics fasting glucagon averaged 110 (+/-9) and in 33 adult-type diabetics the average was 114 (+/-8). The diabetic averages did not differ significantly from the nondiabetic subjects; however, when hyperglycemia was induced by glucose infusion in the nondiabetic subjects so as to simulate the fasting hyperglycemia of the diabetics, mean glucagon fell to 57 mumug (+/-8), which was significantly below the diabetic mean. In 28 healthy subjects the infusion of arginine elicited a rise in glucagon of at least 100 mumug/ml with a peak level averaging 331 mumug/ml (+/-22) at 40 min. This response to arginine was diminished but not abolished during hyperglycemia induced by simultaneous glucose infusion. In everyone of 45 diabetic subjects tested the infusion of arginine elicited a rise in glucagon of at least 140 mumug/ml to levels significantly greater than in nondiabetics. The peak glucagon level in juvenile-type diabetics averaged 458 mumug/ml (SEM +/-36) and in adult-type diabetics averaged 452 mumug/ml (SEM +/-38). The glucagon response to arginine was unrelated to duration of diabetes, to body weight, type of diabetic treatment, or to other known factors. Marked hyperresponsiveness of glucagon to arginine infusion was observed in two patients with advanced Kimmelsteil-Wilson disease. Glucagon levels were markedly elevated in certain patients with severe diabetic ketoacidosis before treatment with insulin. The findings suggest that alpha cell function is inappropriately increased in diabetes mellitus and could play a significant role in the diabetic syndrome.

[1]  E. Samols,et al.  Suppression of pancreatic glucagon release by the hypoglycaemic sulphonylureas. , 1969, Lancet.

[2]  S A BERSON,et al.  Immunoassay of endogenous plasma insulin in man. , 1996, The Journal of clinical investigation.

[3]  R. Williams.  Textbook of Endocrinology , 1951, The Indian Medical Gazette.

[4]  A. Lawrence.  Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration. , 1966, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Grodsky,et al.  Excessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay , 1963, Diabetes.

[6]  R. Unger,et al.  Effects of Starvation on Plasma Pancreatic Glucagon in Normal Man , 1969, Diabetes.

[7]  R. Unger,et al.  Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. , 1968, The Journal of clinical investigation.

[8]  S. Fajans,et al.  Effect of amino acids and proteins on insulin secretion in man. , 1967, Recent progress in hormone research.

[9]  H. Ferner.  The A- and B-cells of the pancreatic islets as sources of the antagonistic hormones glucagon and insulin; the shift of the AB-relation in diabetes mellitus. , 1953, The American journal of digestive diseases.

[10]  R. Unger,et al.  The effects of total starvation upon the levels of circulating glucagon and insulin in man. , 1963, The Journal of clinical investigation.

[11]  R. Unger,et al.  Pancreatic glucagon secretion in normal and diabetic subjects. , 1969, The American journal of the medical sciences.

[12]  V. Marks,et al.  Stimulation of glucagon secretion by oral glucose. , 1965, Lancet.

[13]  V. Herbert,et al.  Coated charcoal immunoassay of insulin. , 1965, The Journal of clinical endocrinology and metabolism.

[14]  S. Berson,et al.  Immunoassay of Endogenous Plasma Insulin in Man , 1960 .

[15]  R. Unger,et al.  Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion. , 1962, The Journal of clinical investigation.

[16]  R. Assan,et al.  [The effects of perfusion and amino acid ingestion in glucagonenemia]. , 1967, Journees annuelles de diabetologie de l'Hotel-Dieu.

[17]  R. Unger,et al.  The role of aminogenic glucagon secretion in blood glucose homeostasis. , 1969, The Journal of clinical investigation.

[18]  W. Hoffman.  A RAPID PHOTOELECTRIC METHOD FOR THE DETERMINATION OF GLUCOSE IN BLOOD AND URINE , 1937 .

[19]  R. Unger,et al.  Glucagon Antibodies and Their Use for Immunoassay for Glucagon.∗ , 1959, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[20]  R. Unger,et al.  Control of Pancreatic Glucagon Secretion by Glucose , 1969, Diabetes.

[21]  R. Unger,et al.  Glucagon antibodies and an immunoassay for glucagon. , 1961, The Journal of clinical investigation.

[22]  R. Unger,et al.  Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. , 1968, The Journal of clinical investigation.

[23]  R. Unger,et al.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. , 1967, The Journal of clinical investigation.

[24]  R. Unger,et al.  Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. , 1968, The Journal of clinical investigation.